<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04835467</url>
  </required_header>
  <id_info>
    <org_study_id>SRFC-IT1501-05</org_study_id>
    <nct_id>NCT04835467</nct_id>
  </id_info>
  <brief_title>First-In-Human Intracoronary OCT-FLIm In Patients Undergoing PCI</brief_title>
  <official_title>First-In-Human Intracoronary Dual-modal Optical Coherence Tomography and Fluorescence Lifetime Imaging (OCT-FLIM) In Patients Undergoing Percutaneous Coronary Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University Guro Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University Guro Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients will undergo intracoronary imaging using combined optical coherence&#xD;
      tomography-fluorescence lifetime imaging (OCT-FLIm) during percutaneous coronary&#xD;
      intervention, and the obtained imaging data will be used to assess the efficacy of this&#xD;
      dual-modal catheter imaging strategy in characterizing high-risk plaque.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fluorescence lifetime imaging (FLIm) is a novel imaging approach allowing label-free&#xD;
      biochemical characterization of atherosclerotic plaque. A combined optical coherence&#xD;
      tomography (OCT) and FLIm that can provide a simultaneous structural and biochemical&#xD;
      assessment of atheroma has been constructed successfully. This study sought to investigate&#xD;
      whether the dual-modal intravascular OCT-FLIm is able to characterize high-risk plaques in&#xD;
      patients undergoing percutaneous coronary intervention.&#xD;
&#xD;
      Thirty two patients with multivessel coronary artery disease, who had at least one&#xD;
      obstructive lesion (&gt;70% diameter stenosis) that is considered suitable for PCI, will be&#xD;
      included in the study. Culprit and mildly stenotic non-culprit plaques will be imaged using&#xD;
      OCT-FLIm catheter.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ability of OCT-FLIm in assessing high-risk plaques</measure>
    <time_frame>day 1</time_frame>
    <description>Lifetime difference according to plaque types</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ability of OCT-FLIm in assessing plaque compositions</measure>
    <time_frame>day 1</time_frame>
    <description>Lifetime difference according to plaque compositions</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Atherosclerosis Coronary Artery With Angina Pectoris</condition>
  <condition>Atheroscleroses, Coronary</condition>
  <condition>Atherosclerotic Plaque</condition>
  <condition>Thin-cap fIbroatheroma</condition>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Intracoronary imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intracoronary imaging during PCI</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dual-modal OCT-FLIm</intervention_name>
    <description>Intracoronary imaging using dual-modal OCT-FLIm catheter</description>
    <arm_group_label>Intracoronary imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: greater than 20, less than 75&#xD;
&#xD;
          -  Patients with significant coronary artery disease (diameter stenosis &gt;70%) requiring&#xD;
             coronary revascularization&#xD;
&#xD;
          -  Reference vessel diameter: between 2.5 and 4.0 mm&#xD;
&#xD;
          -  Obtained informed consent from voluntary participants before study enrollment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Complex coronary lesion (ostial lesion, unprotected left main lesion, chronic total&#xD;
             occlusion, grafted vessels, etc)&#xD;
&#xD;
          -  Reference vessel diameter: less than 2.5 mm, greater than 4.0 mm&#xD;
&#xD;
          -  Coronary lesion with heavy calcification&#xD;
&#xD;
          -  Hemodynamic instability during coronary intervention&#xD;
&#xD;
          -  Contraindication to antithrombotic therapy&#xD;
&#xD;
          -  Chronic renal insufficiency (Serum creatinine &gt;2.0mg/dL)&#xD;
&#xD;
          -  Severe liver dysfunction (AST/ALT &gt; 5 times of upper normal limit)&#xD;
&#xD;
          -  Pregnancy or potential pregnancy&#xD;
&#xD;
          -  Life expectancy less than 1 year&#xD;
&#xD;
          -  Patient refused to sign the informed consent at enrollment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sunwon Kim, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Korea University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dong Oh Kang, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Korea University Guro Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jin Won Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University Guro Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hongki Yoo, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Korea Advanced Institute of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jin Won Kim, MD, PhD</last_name>
    <phone>+82-2-2626-3021</phone>
    <email>kjwmm@korea.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dong Oh Kang, MD, PhD</last_name>
    <phone>+82-2-2626-3184</phone>
    <email>gelly9@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Korea University Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>08308</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Dong Oh Kang, MD, PhD</last_name>
      <phone>+82-2-2626-3184</phone>
      <email>gelly9@naver.com</email>
    </contact>
    <investigator>
      <last_name>Jin Won Kim, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dong Oh Kang, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sunwon Kim, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hongki Yoo, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Lee MW, Song JW, Kang WJ, Nam HS, Kim TS, Kim S, Oh WY, Kim JW, Yoo H. Comprehensive intravascular imaging of atherosclerotic plaque in vivo using optical coherence tomography and fluorescence lifetime imaging. Sci Rep. 2018 Sep 28;8(1):14561. doi: 10.1038/s41598-018-32951-9.</citation>
    <PMID>30267024</PMID>
  </reference>
  <reference>
    <citation>Kim S, Yoo H, Kim JW. Long Journey of Intravascular Imaging: What and How to Look at the Atheroma in Coronary Artery. JACC Cardiovasc Imaging. 2021 Sep;14(9):1843-1845. doi: 10.1016/j.jcmg.2020.11.015. Epub 2020 Dec 16.</citation>
    <PMID>33341412</PMID>
  </reference>
  <reference>
    <citation>Nam HS, Kang WJ, Lee MW, Song JW, Kim JW, Oh WY, Yoo H. Multispectral analog-mean-delay fluorescence lifetime imaging combined with optical coherence tomography. Biomed Opt Express. 2018 Mar 27;9(4):1930-1947. doi: 10.1364/BOE.9.001930. eCollection 2018 Apr 1.</citation>
    <PMID>29675330</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 5, 2021</study_first_submitted>
  <study_first_submitted_qc>April 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University Guro Hospital</investigator_affiliation>
    <investigator_full_name>Jin Won Kim</investigator_full_name>
    <investigator_title>Jin Won Kim, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Fluorescence lifetime imaging</keyword>
  <keyword>High-risk coronary plaque</keyword>
  <keyword>Optical coherence tomography</keyword>
  <keyword>Intravascular imaging</keyword>
  <keyword>Biochemical imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Plaque, Atherosclerotic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

